Avita Medical, Inc.

Good day and thank you for standing by. Welcome to the Aveda Medical fourth quarter 2022 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, press star 1 1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Caroline Corder. Please go ahead.

Thank you, Operator.

Welcome to Avita Medical's fourth quarter 2022 earnings call. Before we begin, let me remind you that this call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding the markets in which Evita Medical operates, trends, demand, and expectations for its products and technology, its expected financial performance, expenses, and position in the markets. These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results, performance, or achievements to differ materially from any results, performance, or achievements expressed or implied by the forward-looking statements. Please review Avita Medical's most recent filings with the SEC, particularly the risks described in Avita Medical's annual report on Form 10-K for the year ended December 31, 2022, for additional information. Any forward-looking statements provided during this call, including projections for future performance, are based on management's expectations as of today. Aveda Medical undertakes no obligation to update these statements except as required by applicable law. Aveda Medical's press release with fourth quarter 2022 results is available on its website, www.avedamedical.com, under the investor section, and includes additional details about its financial results. Aveda Medical's website also has the latest SEC filings, which you are encouraged to review. The recording of today's call will be available on Aveda Medical's website by 5 p.m. Pacific time today. Joining me on today's call are Jim Corbett, Chief Executive Officer, and Sean Deakins, Acting Chief Financial Officer. I'll now turn the call over to Jim for his comments.